Scientific article
English

Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture

Published in

Transplant international, vol. 23, no. 3, p. 259-265

Publication date

2010

Abstract

The culture of human islets is associated with approximately 10-20% islet loss, occasionally preventing transplantation. Preconditioning of the islets to improve postculture yields would be of immediate benefit, with the potential to increase both the number of transplanted patients and their metabolic reserve. In this study, the effect of liraglutide, a long-acting human glucagon-like peptide 1 analogue, on cultured human islets was examined. Culture with liraglutide (1 micromol/l) was associated with a preservation of islet mass (significantly more islets at 24 and 48 h, compared to control; P ≤ 0.05 at 24 and 48 h) and with the presence of larger islets (P ≤ 0.05 at 48 h). These observations were supported by reduced apoptosis rates after 24 h of treatment. We also demonstrated that human islet engraftment is improved in C57Bl/6-RAG(-/-) mice treated with liraglutide 200 microg/kg sc twice daily (P ≤ 0.05), suggesting that liraglutide should be continued after transplantation. Overall, these data demonstrate the beneficial effect of liraglutide on cultured human islets, preserving islet mass. They support the design of clinical studies looking at the effect of liraglutide in clinical islet transplantation.

Keywords

  • Animals
  • Apoptosis/drug effects
  • Female
  • Glucagon-Like Peptide 1/administration & dosage/ analogs & derivatives/pharmacology
  • Graft Survival/drug effects
  • Humans
  • Hypoglycemic Agents/administration & dosage/pharmacology
  • Insulin/metabolism
  • Islets of Langerhans/cytology/ drug effects/metabolism
  • Islets of Langerhans Transplantation/ methods
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Middle Aged
  • Tissue Culture Techniques
  • Transplantation, Heterologous

Citation (ISO format)

TOSO, Christian et al. Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture. In: Transplant international, 2010, vol. 23, n° 3, p. 259–265. doi: 10.1111/j.1432-2277.2009.00984.x

Main files (1)

Article

Identifiers

Journal ISSN

0934-0874
611views
0downloads

Technical informations

Creation

23/05/2012 08:57:55

First validation

23/05/2012 08:57:55

Update

14/10/2025 00:06:26

Status update

14/03/2023 17:36:10

Last indexation

04/02/2026 14:46:35
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated